The nodal location of metastases in melanoma sentinel lymph nodes

American Journal of Surgical Pathology

Volumn 33, Issue 10, 2009, Pages 1522-1528

  Riber Hansen, Rikke ^a   Nyengaard, Jens Randel ^b   Hamilton Dutoit, Stephen Jacques ^a   Steiniche, Torben ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Melanoma; Neoplasm metastasis; Pathology; Sentinel lymph node biopsy

Indexed keywords

HUMAN ALBUMIN COLLOID TC 99M; NANOCOLL TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER LOCALIZATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MELANOMA; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 70349659228     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181b0bd4f     Document Type: Article

References (31)

1. Abrahamsen HN, Hamilton-Dutoit SJ, Larsen J, et al. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer. 2004;100: 1683-1691.
2. Bruel A, Christoffersen TE, Nyengaard JR. Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart. Cardiovasc Res. 2007;76:400-408.
3. Cochran AJ, Morton DL. Detection of clinically relevant melanoma metastases requires focused, not exhaustive, evaluation of sentinel lymph nodes. Am J Surg Pathol. 2006;30:419-420.
4. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol. 1988;12:612-618.
5. Cook MG, Di PS. Pathology of sentinel lymph nodes for melanoma. J Clin Pathol. 2008;61:897-902.
6. Cook MG, Green MA, Anderson B, et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol. 2003;200:314-319.
7. Cserni G. Mapping metastases in sentinel lymph nodes of breast cancer. Am J Clin Pathol. 2000;113:351-354.
8. Cserni G. A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Pathol. 2004;57: 467-471.
9. Debarbieux S, Duru G, Dalle S, et al. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol. 2007;157: 58-67.
10. Diaz LK, Hunt K, Ames F, et al. Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol. 2003; 27:385-389.
11. Dorph-Petersen KA, Nyengaard JR, Gundersen HJ. Tissue shrinkage and unbiased stereological estimation of particle number and size. J Microsc. 2001;204:232-246.
12. Govindarajan A, Ghazarian DM, McCready DR, et al. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol. 2007;14:906-912.
13. Gundersen HJ, Bendtsen TF, Korbo L, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 1988;96:379-394.
14. Howard CV, Reed MG. Unbiased Stereology. New York, USA: BIOS Scientific Publishers; 2005:7-11.
15. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol. 2003;27:1197-1202.
16. Madsen EV, van DJ, van GJ, et al. Strategies for optimizing pathologic staging of sentinel lymph nodes in breast cancer patients. Virchows Arch. 2008;453:17-24.
17. Morton DL, Hoon DS, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg. 2003;238:538-549.
18. Pearlman NW, McCarter MD, Frank M, et al. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg. 2006;192:878-881.
19. Ranieri JM, Wagner JD, Azuaje R, et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol. 2002;9:975-981.
20. Riber-Hansen R, Nyengaard JR, Hamilton-Dutoit S, et al. Metastatic melanoma volume in sentinel nodes: objective stereology- based measurement predicts disease recurrence and survival. Histopathology. 2009;54:796-803.
21. Riber-Hansen R, Sjoegren P, Hamilton-Dutoit SJ, et al. Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workload. Ann Surg Oncol. 2008;15:1492-1501.
22. Riber-Hansen R, Nyengaard JR, Hamilton-Dutoit S, et al. Stage migration after minor changes in histological estimation of tumor burden in sentinel nodes: the protocol trap. Cancer. 2009;115: 2177-2187.
23. Rossi CR, De Salvo GL, Bonandini E, et al. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Ann Surg Oncol. 2008;15:1202-1210.
24. Satzger I, Volker B, Al GM, et al. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology. 2007;50:764-772. (Pubitemid 46683934)
25. Scheri RP, Essner R. Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma. Expert Rev Anticancer Ther. 2006;6:1105-1110.
26. Scheri RP, Essner R, Turner RR, et al. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol. 2007;14:2861-2866.
27. Spanknebel K, Coit DG, Bieligk SC, et al. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol. 2005;29:305-317.
28. Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001;91:2110-2121.
29. van Akkooi A, de WJ, Verhoef C, et al. Clinical relevance of melanoma micrometastases (<0.1mm) in sentinel nodes: Are these nodes to be considered negative? Ann Oncol. 2006; 17: 1578-1585.
30. Viehl CT, Guller U, Hamel CT, et al. Carbon dye staining of sentinel lymph nodes facilitates microstaging of colon cancer patients. World J Surg. 2006;30:453-456.
31. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer. 1999;86:617-627.